Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAMBRIDGE NUTRITIONAL SCIENCES PLC AGM Information 2023

Sep 6, 2023

7544_agm-r_2023-09-06_fc0bd0ee-7638-4304-a61e-038723c5681c.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5870L

Omega Diagnostics Group PLC

06 September 2023

Omega Diagnostics Group plc

('Omega' or the 'Company')

Result of AGM

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that all resolutions were duly passed on a show of hands at the Annual General Meeting held earlier today.

The results of the AGM will be made available on the Company's website:  https://www.omegadx.com/Investor-Relations/Corporate-Information

Contacts: 

Omega Diagnostics Group PLC www.omegadx.com
Jag Grewal, Chief Executive Officer via Walbrook PR
finnCap Ltd Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus / Lianne Applegarth Mob: 07980 541 893 / 07584 391 303
Sam Allen Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

www.omegadx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSSIFFMEDSESU